Linker C - Search Results

1

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia.

Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC Jr, Beer M, Ahmed T. Feldman EJ, et al. Among authors: linker c. Leukemia. 1997 Apr;11(4):485-9. doi: 10.1038/sj.leu.2400623. Leukemia. 1997. PMID: 9096687 Clinical Trial.

2

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.

Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA. Damon LE, et al. Cancer Chemother Pharmacol. 2004 Jun;53(6):468-74. doi: 10.1007/s00280-003-0758-x. Epub 2004 Jan 29. Cancer Chemother Pharmacol. 2004. PMID: 15138711 Clinical Trial.

3

Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.

Damon LE, Rugo HS, Ries CA, Linker CA. Damon LE, et al. Among authors: linker ca. Leukemia. 1994 Apr;8(4):535-41. Leukemia. 1994. PMID: 8152248

4

Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.

Damon LE, Rugo HS, Ries CA, Linker CA. Damon LE, et al. Among authors: linker ca. Bone Marrow Transplant. 1996 Jan;17(1):93-9. Bone Marrow Transplant. 1996. PMID: 8673063

5

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA. Smith GA, et al. Among authors: linker ca. J Clin Oncol. 1997 Feb;15(2):833-9. doi: 10.1200/JCO.1997.15.2.833. J Clin Oncol. 1997. PMID: 9053511

6

High-dose chemotherapy (CTM) for breast cancer.

Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA. Damon LE, et al. Among authors: linker ca. Bone Marrow Transplant. 2000 Aug;26(3):257-68. doi: 10.1038/sj.bmt.1702481. Bone Marrow Transplant. 2000. PMID: 10967563 Clinical Trial.

7

High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.

Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C. Gunn N, et al. Among authors: linker c. Biol Blood Marrow Transplant. 2003 Oct;9(10):643-8. doi: 10.1016/s1083-8791(03)00232-5. Biol Blood Marrow Transplant. 2003. PMID: 14569560 Free article. Clinical Trial.

8

The association between high-dose cytarabine neurotoxicity and renal insufficiency.

Damon LE, Mass R, Linker CA. Damon LE, et al. Among authors: linker ca. J Clin Oncol. 1989 Oct;7(10):1563-8. doi: 10.1200/JCO.1989.7.10.1563. J Clin Oncol. 1989. PMID: 2778484

9

Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.

Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL. Linker CA, et al. Semin Oncol. 1993 Aug;20(4 Suppl 4):40-8; quiz 49. Semin Oncol. 1993. PMID: 8342075

10

Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.

Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Linker CA, et al. Blood. 1993 Jan 15;81(2):311-8. Blood. 1993. PMID: 8422457 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters